RNA interference (RNAi) is emerging as a powerful tool for mammalian genetic screens. The mission of the Broad RNAi Platform is to realize the enormous potential of RNAi to identify the genes underlying disease processes and to elucidate fundamental biological mechanisms. The RNAi Platform grew out of The RNAi Consortium (TRC), a collaborative effort of six academic research institutions and five leading life sciences organizations. The RNAi Platform and TRC work as an integrated team to develop the materials and technology to enable and enhance RNAi as a tool for mammalian genetic screening. The materials and knowledge generated by this team will be made available to the entire scientific community.
The RNAi Platform is directed by David Root, a physical chemist with significant experience in cell-based screening and building lentiviral-based libraries.